Entering text into the input field will update the search result below

BG Medicine, Inc. (BGMD) Names Dr. Paul Sohmer As New CEO

May 09, 2013 2:18 PM ETBGMD
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

BG Medicine is a diagnostics company focused on the development and commercialization of novel cardiovascular tests. The company has two products: the Galectin-3 test for use in patients with chronic heart failure and the CardioSCORE test for the risk prediction of major cardiovascular events.

The company announced today that it has appointed Paul Sohmer, M.D., as its president and chief executive officer and a member of its Board of Directors. He replaces Eric Bouvier as CEO. Dr. Sohmer brings more than 25 years of experience leading the growth of commercial-stage companies focused on diagnostics, laboratory services, and medical devices.

Dr. Sohmer most recently served as president and CEO of Viracor-IBT Laboratories, a diagnostic and research laboratory specializing in allergy, immunology, and infectious disease testing. Prior to that, he was CEO of Orthocon, a developer, manufacturer, and marketer of implantable medical products. Sohmer also has served as interim CEO of Cylex and CEO of Pathway Diagnostics.

In addition, Dr. Sohmer was president and CEO of Neuromedical Systems before its acquisition by TriPath Imaging. He then became TriPath's chairman, president, and CEO before it was acquired by the giant medical technology company Becton, Dickinson. Earlier in his career, Sohmer served as president and CEO of Genetrix, a genetic testing lab that was acquired by Genzyme.

Dr. Sohmer said, "Our challenge now is to unlock the clinical and commercial potential of the company's innovative diagnostic tests. Going forward we will work to enhance and leverage our assets to create a commercial engine that will allow us to grow and drive our margin."

For additional information about BG Medicine and its two innovative diagnostic tests, please visit bg-medicine.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for "The QualityStocks Daily Newsletter" at QualityStocks.net

The Quality Stocks Daily Blog blog.qualitystocks.net

The Quality Stocks Daily Videos videocharts.qualitystocks.net

The Quality Stocks "Ones to Watch" gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You